Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hardman

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Journal of Human Hypertension|July 21, 2001
Erythrocyte sodium-lithium countertransport in African American womenT C Hardman, A S Wierzbicki
Journal of Hypertension|June 1, 1996
Controversies surrounding erythrocyte sodium-lithium countertransportT C Hardman, A F Lant
Cancer|August 19, 2021
Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based studyJohn C Hardman, Theofano Tikka, Vinidh Paleri, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 19, 2026
Facial Canal Dehiscence: Systematic Review and Meta-analysis of Prevalence in Healthy SubjectsPreena Patel, Riccardo Ansbro, John C Hardman
The British Journal of Dermatology|September 6, 2000
Multicentric reticulohistiocytosis associated with Sjögren's syndromeR Morris-Jones, M Walker, C Hardman
Veterinary Ophthalmology|May 20, 2003
The use of transscleral cyclophotocoagulation with a diode laser for the treatment of glaucoma occurring post intracapsular extraction of displaced lenses: a retrospective study of 15 dogs (1995-2000)A O'Reilly, C Hardman, R G Stanley
The Journal of Membrane Biology|January 22, 1998
Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologiesT C Hardman, T Thomas, A F Lant
International Journal of Clinical Practice|February 21, 2012
New lipid-lowering drugs: an updateA S Wierzbicki, T C Hardman, A Viljoen
Expert Opinion on Investigational Drugs|April 13, 2012
Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemiaAnthony S Wierzbicki, Timothy C Hardman, Adie Viljoen
Nucleic Acids Research|July 25, 2000
The effect of chromatin structure on cisplatin damage in intact human cellsN P Davies, L C Hardman, V Murray
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Journal of Human Hypertension|July 21, 2001
Erythrocyte sodium-lithium countertransport in African American womenT C Hardman, A S Wierzbicki
Journal of Hypertension|June 1, 1996
Controversies surrounding erythrocyte sodium-lithium countertransportT C Hardman, A F Lant
Cancer|August 19, 2021
Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based studyJohn C Hardman, Theofano Tikka, Vinidh Paleri, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 19, 2026
Facial Canal Dehiscence: Systematic Review and Meta-analysis of Prevalence in Healthy SubjectsPreena Patel, Riccardo Ansbro, John C Hardman
The British Journal of Dermatology|September 6, 2000
Multicentric reticulohistiocytosis associated with Sjögren's syndromeR Morris-Jones, M Walker, C Hardman
Veterinary Ophthalmology|May 20, 2003
The use of transscleral cyclophotocoagulation with a diode laser for the treatment of glaucoma occurring post intracapsular extraction of displaced lenses: a retrospective study of 15 dogs (1995-2000)A O'Reilly, C Hardman, R G Stanley
The Journal of Membrane Biology|January 22, 1998
Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologiesT C Hardman, T Thomas, A F Lant
International Journal of Clinical Practice|February 21, 2012
New lipid-lowering drugs: an updateA S Wierzbicki, T C Hardman, A Viljoen
Expert Opinion on Investigational Drugs|April 13, 2012
Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemiaAnthony S Wierzbicki, Timothy C Hardman, Adie Viljoen
Nucleic Acids Research|July 25, 2000
The effect of chromatin structure on cisplatin damage in intact human cellsN P Davies, L C Hardman, V Murray
Pageof 14